Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 5/20 | 0.39 |
| ▸ | PPARD | Q03181 | 5/20 | 0.39 |
| ▸ | PPARA | Q07869 | 5/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735260 | 0.98 | TSHR (0.48) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL8736846 | 0.98 | TSHR (0.53) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL8734939 | 0.98 | TSHR (0.48) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL8733717 | 0.98 | TSHR (0.48) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL8733702 | 0.98 | TSHR (0.48) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL27274533 | 0.96 | TSHR (0.52) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL10534570 | 0.96 | TSHR (0.52) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL27272549 | 0.96 | TSHR (0.52) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL27270393 | 0.96 | TSHR (0.52) | TSHRALDH1A1CYP1A2USP2LMNA | |
| SCHEMBL8735253 | 0.96 | TSHR (0.52) | TSHRALDH1A1CYP1A2USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3430111-A1 | PERFUME COMPOSITIONS | Givaudan SA (CH) | 2019-01-23 | — | — | EP | claimed |
| WO-2017157985-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-21 | — | — | WO | claimed |
| US-20250235136-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-24 | — | — | US | disclosed |
| US-12336820-B2 | Methods of preparing/optimizing perfume compositions | GIVAUDAN SA (CH) | 2025-06-24 | — | — | US | disclosed |
| US-12319647-B2 | 2-(2,4,5-trimethylcyclohex-2-en-1-yl)acetaldehyde and derivatives and their use as aroma chemicals | BASF SE (DE) | 2025-06-03 | — | — | US | disclosed |
| US-20250032375-A1 | SOLVENT MIXTURES COMPRISING 1,3-BUTYLENE GLYCOL AND TRIETHYL-CITRATE | GIVAUDAN SA (CH) | 2025-01-30 | — | — | US | disclosed |
| US-12195698-B2 | Fragrance compound providing lily of the valley fragrance characteristics, and fragranced compositions comprising the same | GIVAUDAN SA (CH) | 2025-01-14 | — | — | US | disclosed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | disclosed |
| US-20240352490-A1 | NOVEL PRODUCTION OF AROMA COMPOUNDS WITH IONYLIDENEETHANE SYNTHASES | BASF SE (DE) | 2024-10-24 | — | — | US | disclosed |
| US-12012570-B2 | Acetate compounds useful as odorants | GIVAUDAN SA (CH) | 2024-06-18 | — | — | US | disclosed |
| US-20230212483-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-07-06 | — | — | US | disclosed |
| US-20120004156-A1 | RINSE ADDED AMINOSILICONE CONTAINING COMPOSITIONS AND METHODS OF USING SAME | THE PROCTER & GAMBLE COMPANY | 2012-01-05 | — | — | US | disclosed |
| US-20110257430-A1 | NOVEL COCRYSTALLIZATION | APTUIT (KANSAS CITY), LLC (US) | 2011-10-20 | — | — | US | disclosed |
| US-20100325812-A1 | Rinse Added Aminosilicone Containing Compositions and Methods of Using Same | THE PROCTER & GAMBLE COMPANY | 2010-12-30 | — | — | US | disclosed |
| US-20100267601-A1 | FABRIC CARE COMPOSITIONS COMPRISING ORGANOSILOXANE POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2010-10-21 | — | — | US | disclosed |
| US-20090281195-A1 | NOVEL COCRYSTALLIZATION | S.S.C.I., INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012570-B2 | Acetate compounds useful as odorants | OR10J3, OR51E2, TRPA1 | TSHR 4429/4885ALDH1A1 6/4885CYP1A2 657/4885 |
| US-12195698-B2 | Fragrance compound providing lily of the valley fragrance characteristics, and fragranced compositions comprising the same | MDH2, MDH1, TRPV1 | TSHR 4765/4885ALDH1A1 237/4885CYP1A2 122/4885 |
| US-12319647-B2 | 2-(2,4,5-trimethylcyclohex-2-en-1-yl)acetaldehyde and derivatives and their use as aroma chemicals | ADH5, ECH1, ALG3 | TSHR 4349/4885ALDH1A1 4/4885CYP1A2 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.